Presentation

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

Presenter: Gregg Stone

September 26, 2019

REGISTER for free or LOG IN to view this content

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

Coronary

Presentation

TCT 2019

ACS/AMI

Up Next

Presentation

Utility of Coronary Physiology Assessment in the Asymptomatic Patient

Presenter: Stephane Fournier

September 26, 2019

More slides +

Presentation

Wearable Device for Continuous, Noninvasive Monitoring of Vascular Access Health and Fluid Status in Hemodialysis Patients (GraftWorx)

Presenter: William Gray

September 26, 2019

Presentation

Neurovascular Team: IC Perspective

Presenter: Lawrence Garcia

September 26, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.